Operating income decreased 30.5%
Operating income changed -30.5% from the comparable as-filed period.
-$13.7M→-$17.9M0 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HTFL financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 365 bp higher
Operating margin changed +365 basis points from the comparable as-filed period.
-31.58%→-27.93%0 prior comparisons
Revenue increased 47.6%
Revenue changed +47.6% from the comparable as-filed period.
$43.4M→$64.1M0 prior comparisons
Gross margin moved 752 bp higher
Gross margin changed +752 basis points from the comparable as-filed period.
75.48%→83.00%0 prior comparisons
Research & development increased 74.7%
Research & development changed +74.7% from the comparable as-filed period.
$15.0M→$26.3M0 prior comparisons
Cash & equivalents decreased 57.2%
Cash & equivalents changed -57.2% from the comparable as-filed period.
$80.2M→$34.4M0 prior comparisons
Trade receivables increased 44.0%
Trade receivables changed +44.0% from the comparable as-filed period.
$29.7M→$42.8M0 prior comparisons
Working capital increased 110.4%
Working capital changed +110.4% from the comparable as-filed period.
$85.5M→$179.9M0 prior comparisons
Total assets increased 116.1%
Total assets changed +116.1% from the comparable as-filed period.
$159.4M→$344.5M0 prior comparisons
Selling, general & administrative increased 42.5%
Selling, general & administrative changed +42.5% from the comparable as-filed period.
$31.5M→$44.8M0 prior comparisons
Gross profit increased 62.3%
Gross profit changed +62.3% from the comparable as-filed period.
$32.8M→$53.2M0 prior comparisons
Current liabilities increased 33.8%
Current liabilities changed +33.8% from the comparable as-filed period.
$32.9M→$44.1M0 prior comparisons
Current assets increased 89.1%
Current assets changed +89.1% from the comparable as-filed period.
$118.4M→$224.0M0 prior comparisons
SBC / revenue moved 716 bp higher
SBC / revenue changed +716 basis points from the comparable as-filed period.
5.19%→12.35%0 prior comparisons
Stock-based compensation increased 251.2%
Stock-based compensation changed +251.2% from the comparable as-filed period.
$2.3M→$7.9M0 prior comparisons
R&D / revenue moved 636 bp higher
R&D / revenue changed +636 basis points from the comparable as-filed period.
34.62%→40.98%0 prior comparisons
Current ratio increased 41.3%
Current ratio changed +41.3% from the comparable as-filed period.
3.6→5.080 prior comparisons
Receivables / revenue moved 164 bp lower
Receivables / revenue changed -164 basis points from the comparable as-filed period.
68.37%→66.73%0 prior comparisons
Shares outstanding increased 4.3%
Shares outstanding changed +4.3% from the comparable as-filed period.
83,396,102→86,953,6270 prior comparisons
Working capital / assets moved 143 bp lower
Working capital / assets changed -143 basis points from the comparable as-filed period.
53.65%→52.22%0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.